Integrative review of managed entry agreements: chances and limitations

10 October 2020 - Managed entry agreements consist of a set of instruments to reduce the uncertainty and the budget impact ...

Read more →

Decision criteria that influence managed entry agreements

3 January 2019 - Managed entry agreements enable payers to subsidise access to new medicines while addressing uncertainties.  ...

Read more →

The Australian Managed Entry Scheme: are we getting it right?

23 April 2018 - In 2010, the Australian Government introduced the managed entry scheme (MES) to improve patient access to subsidised ...

Read more →

Characteristics of managed entry agreements in Australia

26 December 2017 - Australia relies on managed entry agreements for many medicines added to the national Pharmaceutical Benefits Scheme.  ...

Read more →

Access to Medicines Working Group communiques

8 September 2016 - The communiques from the February 2015, September 2015 and April 2016 meetings of the Access to Medicines ...

Read more →